Article
K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Cancer - 1 Jan 1998
Wilentz R E, Chung C H, Sturm P D, Musler A, Sohn T A, Offerhaus G J, Yeo C J, Hruban R H, Slebos R J
Abstract excerpt
BACKGROUND: Many patients with carcinoma of the pancreas die because their disease is not detected until late in its course. Methods that detect these cancers earlier will improve patient outcome. Over 80% of pancreatic carcinomas contain mutations in codon 12 of the K-ras gene. Screening duodenal fluid for these mutations may lead to early detection of these cancers and assist in establishing a diagnosis of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.